# Safety, Tolerability, and Pharmacokinetics of Single Dose TenoMiR as a Treatment for Tennis Elbow

> **NCT04670289** · PHASE1 · COMPLETED · sponsor: **Causeway Therapeutics** · enrollment: 24 (actual)

## Conditions studied

- Tennis Elbow

## Interventions

- **DRUG:** TenoMiR (Low Dose)
- **DRUG:** TenoMiR (Medium Dose)
- **DRUG:** TenoMiR (High Dose)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04670289
- **Lead sponsor:** Causeway Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-14
- **Primary completion:** 2021-05-19
- **Final completion:** 2021-08-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04670289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04670289, "Safety, Tolerability, and Pharmacokinetics of Single Dose TenoMiR as a Treatment for Tennis Elbow". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04670289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*